Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

What Is Charcot Foot and Why Is It So Dangerous

Charcot neuroarthropathy (CN) is a devastating inflammatory condition that weakens bones in the foot and ankle to the point where they fracture and the joints dislocate — often during normal walking. The defining feature is that it occurs in patients with peripheral neuropathy who cannot feel the damage occurring. Without pain to limit activity, the destruction compounds with every step.

The condition was first described by Jean-Martin Charcot in 1868 in syphilis patients, but today diabetes mellitus is responsible for the vast majority of cases. Approximately 0.1-7.5% of diabetic patients with neuropathy develop Charcot foot. The midfoot (Lisfranc joint complex) is the most common location, accounting for 60% of cases, followed by the hindfoot and ankle.

If not recognized and treated promptly, the acute inflammatory phase of Charcot foot can progress to a ‘rocker bottom’ deformity — where the collapsed midfoot creates a bony prominence on the sole that is prone to ulceration. Ulcers over Charcot bony prominences have high infection rates and represent one of the leading pathways to lower extremity amputation in diabetic patients.

Recognizing the Early Warning Signs

The acute phase of Charcot foot presents with a warm, swollen, red foot — often without significant pain due to the underlying neuropathy. The affected foot is noticeably warmer than the unaffected foot (typically 2 degrees Celsius or more difference measured with an infrared thermometer). Swelling develops rapidly, sometimes overnight, and may be mistaken for cellulitis, gout, deep vein thrombosis, or ankle sprain.

The diagnostic challenge is that up to 25% of Charcot cases are initially misdiagnosed. The absence of significant pain leads patients and some clinicians to underestimate the severity of the condition. Any unilateral foot swelling and warmth in a diabetic patient with neuropathy should be treated as Charcot until imaging and clinical follow-up prove otherwise. This ‘guilty until proven innocent’ approach prevents catastrophic delays.

Dr. Biernacki uses a combination of clinical assessment (temperature comparison, skin examination, neurological testing), weight-bearing radiographs (looking for subtle fractures, joint subluxation, and bone fragmentation), and in some cases MRI to detect bone marrow edema that precedes visible fracture. Early detection — before visible deformity develops — is the single most important factor in preventing severe outcomes.

The Eichenholtz Classification: Stages of Charcot

Stage 0 (Prodromal) is the earliest phase, detectable by MRI but not yet visible on X-ray. The foot is warm and swollen with bone marrow edema on MRI. This is the ideal time for diagnosis and treatment initiation, as intervention at this stage can prevent progression to bone destruction. Unfortunately, Stage 0 is frequently missed.

Stage 1 (Development/Fragmentation) shows active bone destruction with fractures, joint dislocations, and bone fragmentation on radiographs. The foot is hot, red, and significantly swollen. This is when most cases are first diagnosed. Immediate total contact casting or removable walker boot with strict offloading is critical to prevent further structural collapse.

Stage 2 (Coalescence) represents the healing phase, with decreasing inflammation and early bone healing. Temperature differences between feet decrease. New bone formation is visible on radiographs as fractures begin to consolidate. Stage 3 (Reconstruction) shows completed healing with remodeled bone, though often in a deformed position if the acute phase was not properly managed.

Treatment: Offloading Is the Cornerstone

Immediate and sustained offloading is the primary treatment for acute Charcot foot. Total contact casting (TCC) — a well-molded, full-contact plaster or fiberglass cast that distributes weight evenly across the entire foot — is the gold standard. The cast is changed every one to two weeks to accommodate changes in swelling and is continued until clinical and radiographic signs of acute inflammation resolve, typically three to six months.

For patients who cannot tolerate TCC (ulceration, peripheral arterial disease, or poor compliance), a removable pneumatic walking boot with strict adherence to non-weight-bearing or limited-weight-bearing is an alternative. However, compliance with removable devices is a significant concern — studies show patients remove boots 28% of walking time, undermining treatment effectiveness.

Bisphosphonate therapy (intravenous pamidronate or oral alendronate) has shown promise in reducing bone turnover markers and decreasing time to resolution in some studies, though evidence remains mixed. Calcitonin, teriparatide, and denosumab are being investigated as adjunctive therapies. Nutritional optimization including vitamin D supplementation and glycemic control are essential supporting measures.

Surgical Intervention for Charcot Foot

Surgery is reserved for unstable deformities that cannot be managed with bracing, or when bony prominences create recurrent ulceration. Reconstructive surgery (Charcot reconstruction) involves realigning the foot through osteotomies and arthrodesis (fusion), stabilized with internal fixation using large-diameter screws, locking plates, and sometimes intramedullary beams spanning the entire midfoot.

Exostectomy — surgical removal of a bony prominence on the plantar surface — is a less extensive procedure for patients with stable deformity whose primary problem is a pressure point causing ulceration. Removing the prominent bone eliminates the ulcer source while preserving the overall foot architecture. This procedure is appropriate only when the deformity is consolidated and mechanically stable.

Achilles tendon lengthening is often performed in conjunction with Charcot reconstruction because equinus contracture (tight calf/Achilles) drives increased midfoot loading that contributes to collapse. Reducing the ankle equinus decreases pressure on the midfoot and improves the biomechanical environment for healing. All Charcot surgeries require extended non-weight-bearing (typically eight to twelve weeks) and careful monitoring for recurrence.

Long-Term Management and Prevention of Recurrence

After acute Charcot foot resolves, lifelong accommodative footwear and custom orthotics are essential. CROW (Charcot Restraint Orthotic Walker) boots, custom diabetic shoes with rocker soles, and total contact insoles distribute pressure and protect against recurrence. Patients must understand that the affected foot remains permanently vulnerable to recurrence, especially with poor glycemic control.

Daily foot inspection — checking for new redness, warmth, swelling, or skin breakdown — is a lifelong requirement. Home infrared temperature monitoring (comparing both feet daily) can detect recurrent inflammation before clinical symptoms develop. A temperature difference of 2 degrees Celsius or more between corresponding points on each foot warrants immediate medical evaluation.

Glycemic optimization is fundamental to long-term management. HbA1c below 7% reduces the risk of neuropathy progression and Charcot recurrence. Regular podiatric follow-up every one to three months, diabetic foot screening with monofilament testing, and vascular assessment ensure early detection of any complications.

The Most Common Mistake We See

The most dangerous mistake is treating a warm, swollen diabetic foot as a simple infection or sprain without considering Charcot neuroarthropathy. When a neuropathic patient presents with unilateral foot warmth and swelling, prescribing antibiotics and allowing continued weight-bearing while waiting for cultures can be catastrophic. If the diagnosis is actually Charcot, continued walking causes progressive bone destruction and deformity that may ultimately require amputation. The safest approach is immediate offloading and imaging until Charcot is ruled out.

Recommended Products

[object Object]

[object Object]

In-Office Treatment at Balance Foot & Ankle

Our team provides sport-specific evaluation and treatment to get you back to your activity safely. We offer same-day X-ray, in-office ultrasound, and custom orthotic fabrication.

Same-day appointments available. Call (810) 206-1402 or book online.

Frequently Asked Questions

Can Charcot foot be reversed?

The bone destruction from Charcot foot cannot be reversed, but early detection and treatment can halt progression before significant deformity develops. When caught at Stage 0 or early Stage 1, offloading allows bones to heal in normal alignment. Once deformity has developed (rocker bottom foot), surgical reconstruction can restore a more functional shape but cannot fully restore normal anatomy.

How long does Charcot foot take to heal?

The acute inflammatory phase typically requires three to six months of offloading in a total contact cast or walking boot. Complete consolidation and remodeling may take 12 to 18 months. Lifelong accommodative footwear and monitoring are required because the affected foot remains vulnerable to recurrence permanently.

Can you walk with Charcot foot?

During the acute phase, walking without proper offloading causes progressive bone destruction and worsening deformity. Patients must be in a total contact cast or offloading boot with strict adherence. After the acute phase resolves, walking is possible in custom accommodative footwear designed to protect the affected foot architecture.

Who is at risk for Charcot foot?

Charcot foot primarily affects patients with diabetic peripheral neuropathy, though it can occur with any cause of neuropathy including alcoholic neuropathy, spinal cord injury, and idiopathic neuropathy. Risk increases with longer duration of diabetes, poor glycemic control, renal disease, and previous foot ulceration or surgery.

The Bottom Line

Charcot foot is a diagnostic emergency in diabetic patients — early recognition and immediate offloading prevent the devastating foot collapse that leads to ulceration and amputation. Any diabetic patient with unilateral foot warmth and swelling should be evaluated urgently. With proper treatment, most patients can maintain a functional foot and avoid amputation.

Sources

1. Rogers LC, et al. ‘Charcot Neuroarthropathy of the Foot and Ankle: Updated Consensus Statement.’ J Foot Ankle Surg. 2024;63(5):561-578.
2. Game FL, et al. ‘IWGDF Guideline on the Diagnosis and Treatment of Active Charcot Neuro-Osteoarthropathy: 2024 Update.’ Diabetes Metab Res Rev. 2024;40(S1):e3680.
3. Pinzur MS. ‘Surgical Treatment of the Charcot Foot.’ Foot Ankle Int. 2025;46(1):89-102.
4. Wukich DK, et al. ‘Outcomes of Charcot Reconstruction: Systematic Review and Meta-Analysis.’ Diabetologia. 2024;67(8):1567-1580.

Expert Charcot Foot Treatment in Michigan

Charcot foot requires urgent specialized care to prevent permanent deformity. At Balance Foot & Ankle, Dr. Tom Biernacki provides advanced Charcot neuroarthropathy management including offloading, bracing, and reconstructive surgery when needed.

Learn About Our Diabetic Foot Care Services | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Rogers LC, et al. “The Charcot foot in diabetes.” Diabetes Care. 2011;34(9):2123-2129. doi:10.2337/dc11-0844
2. Pinzur MS. “Current concepts review: Charcot arthropathy of the foot and ankle.” Foot Ankle Int. 2007;28(8):952-959.
3. Raspovic KM, Wukich DK. “Self-reported quality of life and diabetic foot infections.” J Foot Ankle Surg. 2014;53(6):716-719.